Beverley Moore Gowling Lafleur Henderson LLP
Results 1 to 5 of 59
Biovail v. Apotex; merits of 55.2 proceeding; metformin *
Canada - February 12 2010
The Court dismissed the application for prohibition.
Apotex v. Sanofi; interlocutory motion re: affidavits of documents; clopidogrel *
Canada - February 12 2010
Both parties brought motions for further and better affidavits of documents.
AstraZeneca v. Apotex; interlocutory motion for reply evidence; esomeprazole *
Canada - February 12 2010
The Court dismissed AstraZeneca's appeal from the order of a prothonotary refusing to strike parts of Apotex' evidence and refusing to permit the applicants to file reply.
Janssen-Ortho v. Apotex; interlocutory motion for reply evidence; methylphenidate *
Canada - February 12 2010
In two NOC proceedings, the order of evidence was reversed.
Epicept v. Minister of Health; interlocutory motion for confidentiality; histamine *
Canada - February 12 2010
Epicept has filed for a judicial review of the Minister's decision that its histamine dihydrochloride product is not an innovative drug and is thus not eligible for listing on the register of innovative drugs.
Other Gowling Lafleur Henderson LLP authors
- Anita Nador ,
- Christopher C. Van Barr ,
- Christopher Purdon,
- David K. Law ,
- Davit Akman ,
- Estelle Hjertaas ,
- Gloria Hsi Ph.D.,
- Ian Macdonald,
- Jane E. Clark ,
- Jennifer Wilkie,
- John Norman PhD,
- Kiernan A Murphy ,
- Lisa Sim ,
- Louis Frapporti,
- Marc Richard,
- Mark J. Nicholson ,
- Mark Paciocco ,
- Melissa A. Binns,
- Paul Armitage ,
- Tushar Tangri
